Gelatinase expression in retinoblastoma: Modulation of LHBETATAG retinal tumor development by anecortave acetate

Michaela Bajenaru, Yolanda Piña, Timothy G. Murray, Colleen M. Cebulla, William Feuer, Maria Elena Jockovich, Maria E Marin-Castano

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

PURPOSE. Gelatinases, matrix metalloproteinase (MMP)-2, and MMP-9 are known for their importance in angiogenesis and tumor biology. The purpose of this study was to test the hypothesis that anecortave acetate (AA) decreases transgenic retinoblastoma (RB) tumor burden by modulating gelatinase activity. METHODS. To assess the possible gelatinase modulation after AA treatment, a single subconjunctival injection of AA (300 μg) was delivered to the right eyes of 10-week-old LHBETATAG mice. Eyes were evaluated for gelatinase expression and activity by gel and in situ zymography at 24 hours, 48 hours, and 1 week after treatment. RESULTS. Gel zymography of whole eye extracts and in situ zymography of retinal tumors showed strong gelatinase expression and activity within transgenic RB tumors. AA treatment in RB transgenic mice resulted in a significant decrease of gelatinase activity 1 week after AA treatment. Surprisingly, there was an initial transient upregulation of MMP-9 activity in whole eye extracts at 24 and 48 hours after AA treatment in both LHBETATAG transgenic and wild-type mice. This increase was not observed in the tumors. CONCLUSIONS. As suggested by our data, inhibition of gelatinase activity appears to be a mechanism of action of AA. AA treatment results in a decrease in gelatinase activity that correlates with the significant decrease in tumor burden shown by the authors' previous studies. However, the significance of the initial, transient upregulation of gelatinase by AA injection is unknown, and further studies are warranted. Combining antiangiogenic agents with multiple mechanisms of action has the potential to enhance RB tumor control.

Original languageEnglish (US)
Pages (from-to)2860-2864
Number of pages5
JournalInvestigative Ophthalmology and Visual Science
Volume51
Issue number6
DOIs
StatePublished - Jun 2010

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Gelatinase expression in retinoblastoma: Modulation of LHBETATAG retinal tumor development by anecortave acetate'. Together they form a unique fingerprint.

  • Cite this

    Bajenaru, M., Piña, Y., Murray, T. G., Cebulla, C. M., Feuer, W., Jockovich, M. E., & Marin-Castano, M. E. (2010). Gelatinase expression in retinoblastoma: Modulation of LHBETATAG retinal tumor development by anecortave acetate. Investigative Ophthalmology and Visual Science, 51(6), 2860-2864. https://doi.org/10.1167/iovs.09-4500